Acquisition / mergerNotableFiled on BSE ·

Bliss GVS Pharma Limited undergoes promoter reclassification post acquisition

Bliss GVS Pharma · Pharmaceuticals & Biotechnology

What the filing says

  • Anupam Rasayan India Limited and Mates Visa Consultancy Pvt. Ltd. acquired control on September 28, 2026.
  • Former promoters reclassified from "Promoter and Promoter Group" to "Public" category as per Regulation 31A(10) of SEBI Listing Regulations.
  • Updated promoter list includes 2 Promoters and 13 Promoter Group entities such as Kiran Pallavi Investments LLC and Jayhawk Fine Chemicals Corporation.

Why it's rated notable: The filing reports a change in control completed on September 28, 2026 under the SPA dated May 23, 2026, with the reclassification of the former promoter group and no amount stated, and the change itself was already disclosed on September 28, 2026.

Original filing

Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 ("SEBI Listing Regulations")

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies Ltd

Electrical Equipment

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Bliss GVS Pharma

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.